Janux Therapeutics Inc - ESG Rating & Company Profile powered by AI
This ESG rating includes 17 UN SDGs including: 'Affordable & Clean Energy', 'Responsible Production & Consumption' and 'Partnerships for the Goals'. This webpage contains a Q&A table for Janux Therapeutics Inc. Other corporations in the scoring industry group for Janux Therapeutics Inc are displayed below.
Janux Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 4.0, social score of 1.6 and governance score of 4.8.
3.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1144 | Veerhealth Care Ltd | 3.6 | Medium |
| 1144 | iStreet Network Ltd | 3.6 | Medium |
| 1186 | Janux Therapeutics Inc | 3.5 | Medium |
| 1186 | CRISPR Therapeutics AG | 3.5 | Medium |
| 1186 | Catalent Inc | 3.5 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Janux Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Janux Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Janux Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Janux Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Janux Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Janux Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Janux Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Janux Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Janux Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Janux Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Janux Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Janux Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Janux Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Janux Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Janux Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Janux Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Janux Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Janux Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. In addition, its EGFR-TRACTr is designed to target EGFR in many cancer types with multiple approved monoclonal antibodies. The company was incorporated in 2017 and is headquartered in La Jolla, California.